Cytora Unveils Promising Phase 1/2a Trial Results for Innovative Stem Cell Therapy in Diabetic Foot Ulcers Cytora announces significant success in a Phase 1/2a trial using hOMSCs for treating diabetic foot ulcers, hinting at a revolutionary approach in stem cell therapy.

Cytora Unveils Promising Phase 1/2a Trial Results for Innovative Stem Cell Therapy in Diabetic Foot Ulcers #Israel #Diabetic_Foot_Ulcers #Yokneam #Cytora #Stem_Cell_Treatment